Writing Group Member	Employment	Research Grant	Other Research Support	Speakers’ Bureau/ Honoraria	Expert Witness	Ownership Interest	Consultant/ Advisory Board	Other
Jared W. Magnani	University of Pittsburgh	Doris Duke Charitable Foundation*	None	None	None	None	None	None
Herbert D. Aronow	Warren Alpert Medical School of Brown University, Lifespan Cardiovascular Institute	None	None	None	None	None	None	None
Crystal W. Cené	University of North Carolina at Chapel Hill	None	None	None	None	None	None	None
Victoria Vaughan Dickson	New York University College of Nursing	None	None	None	None	None	None	None
Edward Havranek	Denver Health	AHA (investigator)*; AHRQ (principal investigator)*; NIH (investigator)*; PCORI (principal investigator)*	None	None	None	None	None	None
Lewis B. Morgenstern	University of Michigan Medical School	None	None	None	None	None	None	None
Mahasin S. Mujahid	University of California, Berkeley	NIH (co-investigator and investigator on 2 NIH grants)*; Robert Wood Johnson Foundation (co-investigator on a grant)*	None	None	None	None	None	None
Michael K. Paasche-Orlow	Boston University School of Medicine	None	None	None	None	None	None	None
Amy Pollak	Mayo Clinic	None	None	None	None	None	None	None
Joshua Z. Willey	Columbia University	None	None	None	None	None	None	None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

^*Significant.